| A Study to Assess the Safety, Tolerability and Pharmacokinetics of NXL104 Alone and in Combination With Ceftazidime Administered as Single and Repeated Intravenous Doses in Healthy Japanese Subjects (NCT01291602) | Pfizer | 2011-02-01 |
| Study to Evaluate the Effects of Food Ingestion on the Pharmacokinetics of CHF 5074 in Healthy Young Male Subjects (NCT01258452) | CERESPIR | 2011-02-01 |
| Characterization of Cyanocobalamin in Healthy Voluteers After Intranasal and Intramuscual Administration (NCT01306123) | Swedish Orphan Biovitrum | 2011-02-01 |
| Magnetic Resonance (MR) Guided Focused Ultrasound in the Treatment of Brain Tumors (NCT01698437) | University Children's Hospital, Zurich | 2011-02-01 |
| Pharmacokinetics and Metabolism of Hydrocodone Bitartrate Controlled-Release (HC-CR) in Subjects With Hepatic Impairment (NCT02242734) | Zogenix, Inc. | 2011-02-01 |
| Influence of Mild and Moderate Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of Various Doses of Afatinib (NCT01298063) | Boehringer Ingelheim | 2011-02-01 |
| Saffron Supplementation in Stargardt's Disease (NCT01278277) | Catholic University of the Sacred Heart | 2011-02-01 |
| The Effects of Glucomannan on Weight Loss (NCT01709955) | Northeast College of Health Sciences | 2011-02-01 |
| Valproic Acid With Chemoradiotherapy for Non-Small-Cell Lung Cancer (NCT01203735) | Soroka University Medical Center | 2011-02-01 |
| A Multiple Dose Study Of PF-04620110 In Type 2 Diabetes Patients (NCT01298518) | Pfizer | 2011-02-01 |
| Single Rising Dose Study of BI 135585 XX in Health Asian Male Volunteers. (NCT01291732) | Boehringer Ingelheim | 2011-02-01 |
| Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer (NCT01294826) | Swedish Medical Center | 2011-02-01 |
| Safety and Efficacy Study of PRI-724 in Subjects With Advanced Solid Tumors (NCT01302405) | Prism Pharma Co., Ltd. | 2011-02-01 |
| ExAblate Transcranial MR Guided Focused Ultrasound in the Treatment of Essential Tremor (NCT02037217) | InSightec | 2011-02-01 |
| Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Heart Failure (NCT01300650) | Virginia Commonwealth University | 2011-02-01 |
| Platelet Rich Plasma Injection for Knee Pain (NCT01747018) | The Catholic University of Korea | 2011-02-01 |
| Autologous Bone Marrow Cell Transplantation in Persons With Acute Spinal Cord Injury- An Indian Pilot Study. (NCT02260713) | Indian Spinal Injuries Centre | 2011-02-01 |
| A Study to Evaluate the Interaction of LX4211 and Metformin in Healthy Subjects (NCT01292993) | Lexicon Pharmaceuticals | 2011-02-01 |
| Effect of Flax, Poppy, Sesame & Salba on Postprandial Blood Glucose Response, Vascular, Appetite & Sensory Parameters (NCT01579656) | Unity Health Toronto | 2011-02-01 |
| Pharmacokinetic Study of AG200-15 Transdermal Patch to Three Anatomical Sites in Healthy Females (NCT01422135) | Agile Therapeutics | 2011-02-01 |
| Drug Interaction Study of Digoxin and BI 10773 (NCT01306175) | Boehringer Ingelheim | 2011-02-01 |
| A Single-centre, Randomised, Double-blind, Placebo-controlled, Four Way Crossover Phase I Study to Investigate the Effect on QT/QTc Interval of Ceftazidime NXL104 or Ceftaroline Fosamil NXL104, Compared With Placebo, Using Moxifloxacin (Avelox®) as a Positive Control, in Healthy Male Volunteers (NCT01290900) | Pfizer | 2011-02-01 |
| Safety And Tolerability Of Multiple Doses Of PF-04950615 (RN316) In Subjects With Hypercholesterolemia (NCT01243151) | Pfizer | 2011-02-01 |
| A Study of RO5310074 in Patients With Psoriatic Arthritis (NCT01199809) | Hoffmann-La Roche | 2011-02-01 |
| TMC207TBC1003 - A Study in Healthy Volunteers Investigating the Effect of Single-dose TMC207 on the QT/QTc Interval Under Fed Conditions (NCT01291563) | Tibotec BVBA | 2011-02-01 |
| Pharmacokinetics and Metabolism of Hydrocodone Bitartrate Extended-Release (HC-ER) in Subjects With Renal Impairment (NCT02244762) | Zogenix, Inc. | 2011-02-01 |
| Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Properties of Oral AT-406 in Combination With Daunorubicin and Cytarabine in Patients With Poor-risk Acute Myelogenous Leukemia (AML) (NCT01265199) | Ascenta Therapeutics | 2011-02-01 |
| Dietary Antioxidants, Redox Tone and Health Promotion: an Orthomolecular Study of Interactions (NCT01315977) | The Hong Kong Polytechnic University | 2011-02-01 |
| Safety Study of Combined Systemic and Intraperitoneal Chemotherapy to Treat Stomach Cancer (NCT01525771) | Asan Medical Center | 2011-02-01 |
| C14 Study in Oncology Patients With Advanced and/or Metastatic Solid Tumors (NCT01296568) | Eli Lilly and Company | 2011-02-01 |
| Pilot Study of Hepatitis C Virus Entry Inhibitor (ITX 5061) in Liver Transplant Recipients (NCT01292824) | University of Birmingham | 2011-02-01 |
| Typical Versus Atypical Antipsychotics; Occupation of Striatal Receptors and the Appearance of Extrapyramidal Symptomatology, in Healthy Volunteers (NCT01259973) | Hospital Clinic of Barcelona | 2011-02-01 |
| Safety and Pharmacokinetics of CMX001 in Impaired Hepatic Function and Healthy Subjects (NCT05391724) | Jazz Pharmaceuticals | 2011-02-01 |
| A Pharmacokinetic Study to Assess the Influence of Simultaneous CYP3A4 and P-glycoprotein Inhibition on E7080 Pharmacokinetics Following Single Dose Oral Administration of 5 mg E7080 to Healthy Volunteers (NCT02198170) | Eisai Inc. | 2011-02-01 |
| Safety and Efficacy Study of Autologous Bone Marrow Derived Stem Cell Treatment in Amyotrophic Lateral Sclerosis (NCT01363401) | Corestemchemon, Inc. | 2011-02-01 |
| A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB (NCT01125800) | Novartis Pharmaceuticals | 2011-02-01 |
| Influence of Thoracolumbar Proprioceptive Support in the Segmental Stabilization Training (NCT01481857) | Universidade Federal do Piauí | 2011-02-01 |
| Subject Variability in Two Lots of E5501 Administered to Fed and Fasted Healthy Subjects (NCT01327872) | Eisai Inc. | 2011-02-01 |
| Alternate Dosing Regimens of BG00012 in Healthy Volunteers (NCT01281111) | Biogen | 2011-02-01 |
| A Study to Evaluate Safety and Immunogenicity of AERAS-402 (NCT01378312) | Aeras | 2011-02-01 |
| Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic Anemia (NCT01297972) | University of Sao Paulo | 2011-02-01 |
| A Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZYD1, Following Subcutaneous Administration in Healthy Volunteers (NCT01972893) | Zydus Lifesciences Limited | 2011-02-01 |
| Treatment of Non-infectious Intermediate and Posterior Uveitis Associated Macular Edema With Intravitreal Methotrexate (NCT01314417) | National Eye Institute (NEI) | 2011-02-01 |
| The Effect of Vorinostat on HIV RNA Expression in the Resting CD4+ T Cells of HIV+ Pts on Stable ART (NCT01319383) | University of North Carolina, Chapel Hill | 2011-02-01 |
| A Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B) (NCT01286818) | Eli Lilly and Company | 2011-02-01 |
| Effects of Posaconazole and Voriconazole on the Pharmacokinetics and Pharmacodynamics of Sublingual Buprenorphine (NCT01367808) | Turku University Hospital | 2011-02-01 |
| A Study of Diazepam After Intranasal and Intravenous Administration to Healthy Volunteers (NCT01364558) | University of Minnesota | 2011-02-01 |
| Chronic Resveratrol Supplementation in Healthy Humans (NCT01640197) | Northumbria University | 2011-02-01 |
| PET/CT (Positron Emission Tomography/Computed Tomography) Imaging for Safety and Tolerability and Diagnostic Performance of BAY1075553 in Patients With Prostate Cancer and Healthy Volunteers (NCT01287845) | Lantheus Biosciences Ltd. | 2011-02-01 |
| Study of HCD122 (Lucatumumab) and Bendamustine Combination Therapy in CD40+ Rituximab-refractory Follicular Lymphoma (NCT01275209) | Novartis Pharmaceuticals | 2011-02-01 |
| Safety and Efficacy Study of Idelalisib (GS-1101, CAL-101) in Patients With Previously Treated Low-grade Lymphoma (NCT01306643) | Gilead Sciences | 2011-02-01 |
| Panobinostat Plus Ifosfamide, Carboplatin, and Etoposide (ICE) Compared With ICE For Relapsed Hodgkin Lymphoma (NCT01169636) | M.D. Anderson Cancer Center | 2011-01-31 |
| Evaluation of a New Anti-cancer Immunotherapy in Patients With Non-operable and Progressing Metastatic Cutaneous Melanoma (NCT01213472) | GlaxoSmithKline | 2011-01-31 |
| A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives (NCT01291004) | Teva Branded Pharmaceutical Products R&D, Inc. | 2011-01-31 |
| Bioequivalence Study of Cephalexin Suspension 125 (NCT01767532) | GlaxoSmithKline | 2011-01-30 |
| Bioequivalence Study of Cephalexin Suspension 250 (NCT01767571) | GlaxoSmithKline | 2011-01-30 |
| A Phase I Study of NK Cell Infusion Following Allogeneic Peripheral Blood Stem Cell Transplantation From Related or Matched Unrelated Donors in Pediatric Patients With Solid Tumors and Leukemias (NCT01287104) | National Cancer Institute (NCI) | 2011-01-29 |
| Bortezomib, Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant For High-Risk Stage I or II Multiple Myeloma (NCT01163357) | City of Hope Medical Center | 2011-01-28 |
| A Single-Dose Study to Investigate the Pharmacokinetics of MK-7655 in Participants With Impaired Renal Function (MK-7655-005) (NCT01275170) | Merck Sharp & Dohme LLC | 2011-01-28 |
| A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC) (NCT01240590) | National Cancer Institute (NCI) | 2011-01-26 |
| Ferumoxytol Enhanced MRI for the Detection of Lymph Node Involvement in Prostate Cancer (NCT01296139) | National Cancer Institute (NCI) | 2011-01-26 |
| An Absorption, Distribution, Metabolism and Excretion (ADME) Study of Single Oral Dose [14C] GSK2118436 in Subjects With BRAF Mutant Solid Tumors (NCT01262963) | GlaxoSmithKline | 2011-01-26 |
| Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial (NCT01294358) | National Cancer Institute (NCI) | 2011-01-26 |
| Study to Evaluate Cinacalcet in Children With Chronic Kidney Disease (NCT01290029) | Amgen | 2011-01-25 |
| Trial of GSK1120212 and GSK1120212 in Combination With GEM in Japanese Subjects With Solid Tumors (NCT01324258) | GlaxoSmithKline | 2011-01-24 |
| A Dose Escalation/Expansion Study of LDK378 in Patients With Tumors Characterized by Genetic Abnormalities in Anaplastic Lymphoma Kinase (NCT01283516) | Novartis Pharmaceuticals | 2011-01-24 |
| Azacitidine in Combination With Mitoxantrone, Etoposide Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT01249430) | National Cancer Institute (NCI) | 2011-01-20 |
| Safety/Tolerability/Pharmacokinetic (PK)/Pharmacodynamics (PD) Study of BMN701 in Patients With Late-Onset Pompe Disease (NCT01230801) | BioMarin Pharmaceutical | 2011-01-17 |
| Bioequivalence Study of 300 mg Gabapentin (NCT01738893) | GlaxoSmithKline | 2011-01-14 |
| A First Time in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Single and Repeat Doses of GSK2485852 in Chronically Infected Hepatitis C Subjects (NCT01332552) | GlaxoSmithKline | 2011-01-14 |
| Japanese Study of BMS-901608 (Elotuzumab) in Combination With Lenalidomide and Low Dose Dexamethasone (NCT01241292) | Bristol-Myers Squibb | 2011-01-14 |
| An Open-label, Randomized, Single Period, Parallel-Cohort Study To Evaluate Serum and Pulmonary Pharmacokinetics Following Single and Multiple Dose Administration of Intravenous GSK2251052 in Healthy Adult Subjects (NCT01267968) | GlaxoSmithKline | 2011-01-11 |
| Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma (NCT01075321) | Mayo Clinic | 2011-01-10 |
| Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction (NCT01273155) | National Cancer Institute (NCI) | 2011-01-10 |
| AZD6244 With Cetuximab for Solid Tumors and Colorectal Cancer (NCT01287130) | National Cancer Institute (NCI) | 2011-01-07 |
| Phase1 Study of GR121167, Single and Multiple Dose Study in Healthy Japanese Males (NCT01428479) | GlaxoSmithKline | 2011-01-07 |
| EGFR Inhibition Using Weekly Erlotinib for Recurrent Malignant Gliomas (NCT01257594) | Andrew B Lassman, MD | 2011-01-07 |
| SAP Depleter Dose Escalation Study in Healthy Volunteers (NCT01323985) | GlaxoSmithKline | 2011-01-06 |
| A Repeat Dose Study to Investigate the Interaction of GSK2190915 on the Pharmacokinetics of Rosuvastatin (NCT01411111) | GlaxoSmithKline | 2011-01-06 |
| MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Metastatic Breast Cancer (NCT01263145) | National Cancer Institute (NCI) | 2011-01-05 |
| SGI-110 in Participants With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) (NCT01261312) | Astex Pharmaceuticals, Inc. | 2011-01-04 |
| Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors (NCT01286987) | Pfizer | 2011-01-03 |
| ABT-888 With Modified FOLFOX6 in Patients With Metastatic Pancreatic Cancer (NCT01489865) | Georgetown University | 2011-01-03 |
| Effectiveness of Global Postural Reeducation in Patients With Chronic Symptomatic Lumbar Disc Herniation (NCT01236924) | Universidade Gama Filho | 2011-01-01 |
| A Study of LOR-253 HCl in Patients With Advanced or Metastatic Solid Tumours (NCT01281592) | Aptose Biosciences Inc. | 2011-01-01 |
| AMES Treatment of the Impaired Leg in Chronic Stroke Patients (NCT01378637) | AMES Technology | 2011-01-01 |
| Disposition of 14C-LY2452473 Following Oral Administration in Healthy Human Subjects (NCT01275157) | Eli Lilly and Company | 2011-01-01 |
| A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza (NCT01053663) | Hoffmann-La Roche | 2011-01-01 |
| Bioequivalence Between a Racecadotril Capsule and Film-Coated Tablet (FCT) to Treat Diarrhea in Adults (NCT01302093) | McNeil AB | 2011-01-01 |
| ITT4 Intratesticular Hormonal Milieu in Man (ITT4) (NCT01215292) | University of Washington | 2011-01-01 |
| Lipoic Acid as a Treatment for Acute Optic Neuritis (NCT01294176) | Oregon Health and Science University | 2011-01-01 |
| Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer (NCT01457469) | Wake Forest University Health Sciences | 2011-01-01 |
| Decidual Stromal Cells as Treatment for Acute Graft Versus Host Disease, a Phase 1-2 Study (NCT02172937) | Karolinska Institutet | 2011-01-01 |
| A Dose-escalation Study of Ombrabulin in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Tumors (NCT01293630) | Sanofi | 2011-01-01 |
| Trial of ICM With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic Cancer (NCT01296763) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2011-01-01 |
| Role of Endoscopic RFA in Prolonging the Patency of Metal Stents in Patients With Malignant Obstructive Jaundice (NCT01275768) | Asian Institute of Gastroenterology, India | 2011-01-01 |
| Safety and Efficacy Trial to Treat Open-Angle Glaucoma or Ocular Hypertension (NCT01279083) | Santen Inc. | 2011-01-01 |
| Study in Healthy Volunteers of the Safety and Metabolism of Different Doses of the Anti-HIV Drug TMC278LA. (NCT01275443) | St Stephens Aids Trust | 2011-01-01 |
| TINN Pharmacokinetics (PK) Study Treat Infections iN Neonates (NCT01319435) | Liverpool Women's NHS Foundation Trust | 2011-01-01 |
| BIOAVAILABILITY OF Glimepiride/Extended Release Metformin (GLI/METXR): High Fat Diet Study (NCT01437813) | Laboratorios Silanes S.A. de C.V. | 2011-01-01 |